Literature DB >> 8431668

Pharmacokinetics and effects of mannitol on hemodynamics, blood and cerebrospinal fluid electrolytes, and osmolality during intracranial surgery.

A Rudehill1, E Gordon, G Ohman, C Lindqvist, P Andersson.   

Abstract

Fifteen patients who underwent surgery for intracranial tumors under general anesthesia were given mannitol (1 g/kg of body weight) over 30 min. Measurements of mannitol concentration, osmolality, and electrolytes were determined in blood and cerebrospinal fluid (CSF) samples collected over an 8-h period. Seven sets of hemodynamic observations and four sets of intracranial pressure (ICP) measurements were also made. Mannitol disappeared from plasma in a biexponential manner. The mean maximal plasma concentration was 5.91 mg/ml at the end of mannitol infusion and decreased to 0.58 mg/ml after 8 h. The plasma half-life for the distribution phase was 0.16 h and for the elimination phase was 2.44 h. The distribution volume was 17.0 L and total plasma clearance 87.4 ml/min. There were marked interindividual variations of mannitol concentration in the CSF. The mean CSF concentration at 8 h was 97.1 micrograms/ml, started to decline earlier in 10 of 12 patients, and never exceeded 12% of that in plasma. Osmolality in serum increased with a maximum at the end of mannitol infusion (from 292 +/- 7 mOsmol/kg to 310 +/- 14 mOsmol/kg; p < 0.01), whereas CSF osmolality was unchanged, thus giving rise to a positive blood-CSF osmotic gradient of at least 10 mOsmol/kg for about 30 min. At the end of the mannitol infusion, cardiac output and pulmonary capillary wedge pressure increased significantly, whereas the hematocrit decreased. ICP was observed in five patients for 45 min, and mannitol induced a mean reduction from 11 +/- 4 to 4 +/- 2 mm Hg (p < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8431668     DOI: 10.1097/00008506-199301000-00002

Source DB:  PubMed          Journal:  J Neurosurg Anesthesiol        ISSN: 0898-4921            Impact factor:   3.956


  14 in total

Review 1.  Osmotic therapy: fact and fiction.

Authors:  Michael N Diringer; Allyson R Zazulia
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

2.  Cerebral blood flow velocity after mannitol infusion in children.

Authors:  S G Soriano; M L McManus; L J Sullivan; M A Rockoff; P M Black; F A Burrows
Journal:  Can J Anaesth       Date:  1996-05       Impact factor: 5.063

3.  Pharmacotherapy Pearls for Emergency Neurological Life Support.

Authors:  Gretchen M Brophy; Theresa Human
Journal:  Neurocrit Care       Date:  2017-09       Impact factor: 3.210

Review 4.  Care of the stroke patient: routine management to lifesaving treatment options.

Authors:  George A Lopez; Arash Afshinnik; Owen Samuels
Journal:  Neurotherapeutics       Date:  2011-07       Impact factor: 7.620

5.  Mannitol attenuates acute lung injury induced by infrarenal aortic occlusion-reperfusion in rats.

Authors:  Zafer Teke; Fahri Adali; E Canan Kelten; Yasar Enli; K Gokhan Sackan; Kerem Karaman; Metin Akbulut; Ibrahim Goksin
Journal:  Surg Today       Date:  2011-07-12       Impact factor: 2.549

6.  D-mannitol in cerebrospinal fluid of patients with AIDS and cryptococcal meningitis.

Authors:  G M Megson; D A Stevens; J R Hamilton; D W Denning
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

Review 7.  Osmotherapy for elevated intracranial pressure: a critical reappraisal.

Authors:  R Nau
Journal:  Clin Pharmacokinet       Date:  2000-01       Impact factor: 6.447

Review 8.  Hyperosmolar therapy for intracranial hypertension.

Authors:  Andrew Torre-Healy; Nicholas F Marko; Robert J Weil
Journal:  Neurocrit Care       Date:  2012-08       Impact factor: 3.210

9.  Cryptococcus neoformans responds to mannitol by increasing capsule size in vitro and in vivo.

Authors:  Allan Jefferson Guimarães; Susana Frases; Radamés J B Cordero; Leonardo Nimrichter; Arturo Casadevall; Joshua D Nosanchuk
Journal:  Cell Microbiol       Date:  2010-01-11       Impact factor: 3.715

10.  Effects of Osmotic Therapy on Pupil Reactivity: Quantification Using Pupillometry in Critically Ill Neurologic Patients.

Authors:  C Ong; M Hutch; M Barra; A Kim; S Zafar; S Smirnakis
Journal:  Neurocrit Care       Date:  2019-04       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.